It looks like your are using Internet Explorer.
Unfortunately, Internet Explorer is an outdated browser and we do not currently support it fully. You are seeing a limited view of the meeting details below.
To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.
Sprint: Beyond Piloting: Growth and Scaling of Pharma-DTx Partnerships (Part 1)
Pharma-DTx Partnerships can be a good strategy when they speak the same language. We have seen some successful pilots, but there are some challenges when it comes to figuring out how best to spread and sustain innovations that deliver value at scale with a relevant ROI for the pharma company. What are the main obstacles to the growth and scalability of DTx-Pharma partnerships? What would successful growth and scaling look like and how do we get there?
In this sprint, we will break this down into 5 key challenges and agree on 5 key recommendations to overcome them. At the end of the session, HealthXL will put together an output with the learnings from the group. Some of the major challenges we may tackle (these are some examples - the group will agree on the problems they want to address):
- Customer acquisition cost (CAC) and retention: CAC is usually very high in healthcare, and the revenue from the DTx may not justify the investment. How can pharma build a loyal customer base in a sustainable way as they scale the DTx solution?.
- Ways to evolve physician and patient training and education when scaling and growing the product across different geographies and cultures
- Regulatory landscape and label claims. Regulatory agencies are still in the process of developing universal guidelines for DTx approval and use. Every territory has their rules, how can pharma and DTx companies approach regulations and label claims when scaling across countries?
- Limited and fragmented reimbursement from public and private payers. Every payer has different needs and populations, how can we address this issue when scaling DTx?
- Data privacy, security and ownership
* Please note Part 2 of this Sprint will take place on March 22nd
We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.
An invite invite link has been sent to you if you do not already have a HealthXL account.
An invite link will be sent to your inbox.
Sprint: Beyond Piloting: Growth and Scaling of Pharma-DTx Partnerships (Part 1)
Join this HealthXL Event today:
Participate in this Digital Health Sprint in order to:
- Deep dive into a topic over 2 focused sessions.
- Engage with a small group of 10 global thought-leaders throughout.
- This sprint is outcome-focused: HealthXL and participants create exclusive outputs.
- Grow your network with our break out sessions.
You actively participate in this discussion. Spaces are limited to 8 - 12 people, allowing you to focus on quality in-depth conversations.
Don't miss your opportunity to connect with senior leaders to shape the future of digital health. Because only if you are prepared now can you lead the future.
Pharma-DTx Partnerships can be a good strategy when they speak the same language. We have seen some successful pilots, but there are some challenges when it comes to figuring out how best to spread and sustain innovations that deliver value at scale with a relevant ROI for the pharma company. What are the main obstacles to the growth and scalability of DTx-Pharma partnerships? What would successful growth and scaling look like and how do we get there?
In this sprint, we will break this down into 5 key challenges and agree on 5 key recommendations to overcome them. At the end of the session, HealthXL will put together an output with the learnings from the group. Some of the major challenges we may tackle (these are some examples - the group will agree on the problems they want to address):
- Customer acquisition cost (CAC) and retention: CAC is usually very high in healthcare, and the revenue from the DTx may not justify the investment. How can pharma build a loyal customer base in a sustainable way as they scale the DTx solution?.
- Ways to evolve physician and patient training and education when scaling and growing the product across different geographies and cultures
- Regulatory landscape and label claims. Regulatory agencies are still in the process of developing universal guidelines for DTx approval and use. Every territory has their rules, how can pharma and DTx companies approach regulations and label claims when scaling across countries?
- Limited and fragmented reimbursement from public and private payers. Every payer has different needs and populations, how can we address this issue when scaling DTx?
- Data privacy, security and ownership
* Please note Part 2 of this Sprint will take place on March 22nd
We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.
Participants
Participants
Mirza Ahmed
Senior Director, Hikma Pharmaceuticals
Kevin Darcy
Director, Link Strategy at Veeva Systems
Matt Norton
Vice President of Marketing & Commercial Development at S3 Connected Health
Malin Johansson
Global Head of Digital Health Partnerships at Novo Nordisk
Serdar Gemici
Co-Founder, Albert Health
Ashutosh Malhotra
Digital Business Development & Innovation Scouting Manager Europe at Daiichi Sankyo Europe GmbH
Ralph Morales III
Director, Healthcare Innovation, Oura
Jock Thompson
Chief Revenue Officer, Miku
Valentine Emmanuel
Experience Design & Strategy Lead, Daiichi Sankyo
Ivan Jurisic
Founder/Business Consultant, Patients Influence
Patrick Leyseele
Founder and CEO, 3.life
Tahir Hussain
European BD Director - Digital Therapeutics (DTx), Biofourmis
Carman Ho
Vice President, L1 Health
Up to 12
Sprint: Beyond Piloting: Growth and Scaling of Pharma-DTx Partnerships (Part 1)
Pharma-DTx Partnerships can be a good strategy when they speak the same language. We have seen some successful pilots, but there are some challenges when it comes to figuring out how best to spread and sustain innovations that deliver value at scale with a relevant ROI for the pharma company. What are the main obstacles to the growth and scalability of DTx-Pharma partnerships? What would successful growth and scaling look like and how do we get there?
In this sprint, we will break this down into 5 key challenges and agree on 5 key recommendations to overcome them. At the end of the session, HealthXL will put together an output with the learnings from the group. Some of the major challenges we may tackle (these are some examples - the group will agree on the problems they want to address):
- Customer acquisition cost (CAC) and retention: CAC is usually very high in healthcare, and the revenue from the DTx may not justify the investment. How can pharma build a loyal customer base in a sustainable way as they scale the DTx solution?.
- Ways to evolve physician and patient training and education when scaling and growing the product across different geographies and cultures
- Regulatory landscape and label claims. Regulatory agencies are still in the process of developing universal guidelines for DTx approval and use. Every territory has their rules, how can pharma and DTx companies approach regulations and label claims when scaling across countries?
- Limited and fragmented reimbursement from public and private payers. Every payer has different needs and populations, how can we address this issue when scaling DTx?
- Data privacy, security and ownership
* Please note Part 2 of this Sprint will take place on March 22nd
We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.
HealthXL Meetings
HealthXL Digital Health Meetings connect you with senior leaders around the world to discuss, solve and support each other.
Your time is valuable. This is why each Digital Health Meeting is limited to 75 minutes - long enough for engaging discussions but short enough to fit into your busy weekly schedule.
Digital Health Meetings are fully interactive and promote conversation - be ready to talk!
HealthXL Digital Health Meetings are not webinars. There is no audience, no recordings and no hiding behind a screen. Discuss, reflect and share learnings in a private but interactive group.
No long speeches, no wait, no travel. Take a productive deep dive into different digital health topics in just 75 minutes - perfect for when you’re on a break.
Join a community of gamechangers in digital health. With a HealthXL membership, you meet like-minded people with unique perspectives. And as a HealthXL member, you get access to regular Digital Health Meetings.
Stay informed on the HealthXL Communities Hub. Connect with your peers, receive notifications about the latest interactive Meetings, get curated digital health news and access industry reports, insights, shared resources and more.
Join from anywhere
No need for a high end laptop to display fancy 3D personas or interactive conference rooms: All you need is a working camera and an internet-ready device to join.
The world of Digital Health in one Hub
Be ready for the future of Digital Health and join a community of passionate leaders, innovators and gamechangers.
As a HealthXL member, you get access to a wealth of information, resources and connections. From daily curated news by our in-house expert team to industry reports each retailing at €2000 - you have the world of Digital Health right at your fingertips.
Our community is growing fast. Don’t miss out on your opportunity to lead the future.
News
Your Digital Health Corner
All Posts.png)
.jpg)
.png)
Frequently Asked Questions
What is a HealthXL Digital Health Meeting?
HealthXL Digital Health Meetings are private group meetings limited to a maximum of 10 people across different demographic and stakeholder groups. They are not webinars, but participant-led group meetings to allow you to explore every facet of digital health with peers.
How can I become a member of the Digital Health Community?
We invite you to create a free account on our Community Hub to have a look behind the curtains. We'd love to show you the platform in a personal call. Click here to schedule a free session with a member of our team.
When can I access the Meeting recording?
Our Meetings are all about honest, open discussions. This is why we do not record our them. After each Meeting, if you were a participant, you will receive a link to the key takeaways; a short summary of the Meeting.
I am participating in this meeting, but can't attend anymore. Can I cancel it?
It can always happen that you cannot attend meetings due to unforeseen reasons. Due to the small group size, even missing one person can be disruptive. We'd like to ask all participants to inform us with at least 48 hours notice or suggest a suitable replacement for themselves.
Sprint: Beyond Piloting: Growth and Scaling of Pharma-DTx Partnerships (Part 1)
Sprint: Beyond Piloting: Growth and Scaling of Pharma-DTx Partnerships (Part 1)
Sprint: Beyond Piloting: Growth and Scaling of Pharma-DTx Partnerships (Part 1)
Pharma-DTx Partnerships can be a good strategy when they speak the same language. We have seen some successful pilots, but there are some challenges when it comes to figuring out how best to spread and sustain innovations that deliver value at scale with a relevant ROI for the pharma company. What are the main obstacles to the growth and scalability of DTx-Pharma partnerships? What would successful growth and scaling look like and how do we get there?
In this sprint, we will break this down into 5 key challenges and agree on 5 key recommendations to overcome them. At the end of the session, HealthXL will put together an output with the learnings from the group. Some of the major challenges we may tackle (these are some examples - the group will agree on the problems they want to address):
- Customer acquisition cost (CAC) and retention: CAC is usually very high in healthcare, and the revenue from the DTx may not justify the investment. How can pharma build a loyal customer base in a sustainable way as they scale the DTx solution?.
- Ways to evolve physician and patient training and education when scaling and growing the product across different geographies and cultures
- Regulatory landscape and label claims. Regulatory agencies are still in the process of developing universal guidelines for DTx approval and use. Every territory has their rules, how can pharma and DTx companies approach regulations and label claims when scaling across countries?
- Limited and fragmented reimbursement from public and private payers. Every payer has different needs and populations, how can we address this issue when scaling DTx?
- Data privacy, security and ownership
* Please note Part 2 of this Sprint will take place on March 22nd
We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.
Join this group of peers and get a feel of what it's like to belong to a community of digital health gamechangers.
All meetings are limited to 10 people to allow for honest discussions, so apply fast or become a HealthXL member and get priority access to all meetings, latest industry reports and and much more.
Frequently asked questions:
What are HealthXL Virtual Meetings?
HealthXL Virtual Meetings are private group meetings limited to 10 people across different demographic and stakeholder groups. For 75 minutes, you take a deep dive into your chosen topic and explore it from different angles. Virtual Meetings are not webinars: There is no audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And through our Community Hub, you stay up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.
How can I connect with other digital health leaders?
HealthXL brings together gamechangers of digital health to support honest discussions in small, private groups. In our Community Hub, for which you can register for free, you can follow a wide range of communities across telehealth, digital therapeutics, patient engagement and more. As a full HealthXL member, you also get access to curated news, the latest insights and an expert network to connect with. Join exclusive virtual meetings to exchange strategies, viewpoints and learnings with members from like-minded yet diverse stakeholder groups.
What are the benefits of being a HealthXL community member?
As member of HealthXL, you join a community of digital health thought leaders, innovators and game changers around the world. With your membership, you get access to hundreds of insights, reports and resources. You can browse a database with over 90k healthcare organizations and view their active strategic partnerships, commercial relationships, latest funding rounds and research. Through our in-house curated digital health newsfeed, you stay informed on the most impactful news and you can regularly meet with members to share learnings, discuss the latest developments and connect with peers of different demographical stakeholder groups. Contact us today to find out about pricing options.
Through focus groups, we bring together 6-10 thought leaders and industry stakeholders in a series of virtual meetings to collaborate around a defined topic. Each meeting gives the group the opportunity to examine, analyze and collaborate with one another around a digital health topic as well as produce a shareable result.
